Josh Shapiro

Patients

At BIO 2025, vaccines were top of mind as a result of recent actions by HHS. Speakers addressed news head on, but also explored the larger context.

News

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.